XML 33 R19.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

STOCK-BASED COMPENSATION PLANS | 3 Months Ended
--- | ---
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract] |
STOCK-BASED COMPENSATION PLANS | STOCK-BASED COMPENSATION PLANS The Company has adopted the HBT Financial, Inc. Omnibus Incentive Plan (the “Omnibus Incentive Plan”). The Omnibus Incentive Plan provides for grants of (i) stock options, (ii) stock appreciation rights, (iii) restricted shares, (iv) restricted stock units, (v) performance awards, (vi) other share-based awards and (vii) other cash-based awards to eligible employees, non-employee directors and consultants of the Company. The maximum number of shares of common stock available for issuance under the Omnibus Incentive Plan is 1,820,000 shares. The following is a summary of stock-based compensation expense (benefit):
| Three Months Ended March 31, |  |
(dollars in thousands) | 2024 |  | 2023 |  |  |  |  |  |
Restricted stock units | $ | 273 |  |  | $ | 277 |  |  |  |  |  |  |
Performance restricted stock units | 236 |  |  | 240 |  |  |  |  |  |  |
Total awards classified as equity | 509 |  |  | 517 |  |  |  |  |  |  |
Stock appreciation rights | (129) |  |  | 1 |  |  |  |  |  |  |
Total stock-based compensation expense | $ | 380 |  |  | $ | 518 |  |  |  |  |  |  |
Restricted Stock Units A restricted stock unit grants a participant the right to receive one share of the Company’s common stock, following the completion of the requisite service period. Restricted stock units are classified as equity. Compensation cost is based on the Company’s stock price on the grant date and is recognized on a straight-line basis over the service period for the entire award. Dividend equivalents on restricted stock units, which are either accrued until vested, are classified as dividends charged to retained earnings. During the three months ended March 31, 2024 and 2023, the total grant date fair value of the restricted stock units granted was $1.0 million and $1.0 million, respectively, based on the grant date closing prices. The total intrinsic value of restricted stock units that vested during the three months ended March 31, 2024 and 2023 was $1.4 million and $1.1 million, respectively. The following is a summary of restricted stock unit activity:
| Three Months Ended March 31, |  |  |  |
| 2024 |  | 2023 |  |  |  |
| Restricted Stock Units |  | Weighted Average Grant Date Fair Value |  | Restricted Stock Units |  | Weighted Average Grant Date Fair Value |  |  |  |
Beginning balance | 128,159 |  |  | $ | 19.56 |  |  | 139,986 |  |  | $ | 18.01 |  |  |  |  |
Granted | 51,246 |  |  | 19.06 |  |  | 41,847 |  |  | 22.72 |  |  |  |  |
Vested | (70,540) |  |  | 18.96 |  |  | (51,693) |  |  | 17.91 |  |  |  |  |
Forfeited | — |  |  | — |  |  | (718) |  |  | 16.58 |  |  |  |  |
Ending balance | 108,865 |  |  | $ | 19.71 |  |  | 129,422 |  |  | $ | 19.58 |  |  |  |  |
As of March 31, 2024, unrecognized compensation cost related to the non-vested restricted stock units was $1.7 million. This cost is expected to be recognized over the weighted average remaining service period of 1.9 years. Performance Restricted Stock Units A performance restricted stock unit is similar to a restricted stock unit, except that the number of shares of the Company’s common stock awarded is based on a performance condition and the completion of the requisite service period. The number of shares of the Company’s common stock that may be earned ranges from 0% to 150% of the number of performance restricted stock units granted. Performance restricted stock units are classified as equity. Compensation cost is based on the Company’s stock price on the grant date and an assessment of the probable outcome of the performance condition. Compensation cost is recognized on a straight-line basis over the service period of the entire award. Changes in the performance condition probability assessment result in cumulative catch-up adjustments to the compensation cost recognized. Dividend equivalents on performance restricted stock units, which are accrued until vested, are classified as dividends charged to retained earnings. During the three months ended March 31, 2024 and 2023, the total fair value of the performance restricted stock units granted was $0.4 million and $0.4 million, respectively, based on the grant date closing prices and an assessment of the probable outcome of the performance condition on the grant date. The total intrinsic value of performance restricted stock units that vested during the three months ended March 31, 2024 was $0.8 million. The following is a summary of performance restricted stock unit activity:
| Three Months Ended March 31,
| 2024 |  | 2023 |  |
| Performance Restricted Stock Units |  | Weighted Average Grant Date Fair Value |  | Performance Restricted Stock Units |  | Weighted Average Grant Date Fair Value |  |  |  |
Beginning balance | 79,097 |  |  | $ | 18.25 |  |  | 62,067 |  |  | $ | 17.02 |  |  |  |  |
Granted | 19,933 |  |  | 19.06 |  |  | 17,030 |  |  | 22.72 |  |  |  |  |
Adjustment for performance condition | 14,349 |  |  | 15.53 |  |  | — |  |  | — |  |  |  |  |
Vested | (43,046) |  |  | 15.53 |  |  | — |  |  | — |  |  |  |  |
Forfeited | — |  |  | — |  |  | — |  |  | — |  |  |  |  |
Ending balance | 70,333 |  |  | $ | 19.59 |  |  | 79,097 |  |  | $ | 18.25 |  |  |  |  |
As of March 31, 2024, unrecognized compensation cost related to non-vested performance restricted stock units was $0.6 million, based on the current assessment of the probable outcome of the performance conditions. This cost is expected to be recognized over the weighted average remaining service period of 1.7 years. Stock Appreciation Rights A stock appreciation right grants a participant the right to receive an amount of cash, the value of which equals the appreciation in the Company’s stock price between the grant date and the exercise date. Stock appreciation rights are classified as liabilities. The liability is based on an option-pricing model used to estimate the fair value of the stock appreciation rights. Compensation cost for non-vested stock appreciation rights is recognized on a straight line basis over the service period of the entire award. The following is a summary of stock appreciation rights activity:
| Three Months Ended March 31,
| 2024 |  | 2023 |  |
| Stock Appreciation Rights |  | Weighted Average Grant Date Assigned Value |  | Stock Appreciation Rights |  | Weighted Average Grant Date Assigned Value |  |  |  |
Beginning balance | 73,440 |  | $ | 16.32 |  |  | 73,440 |  | $ | 16.32 |  |  |  |  |
Granted | — |  | — |  |  | — |  | — |  |  |  |  |
Exercised | — |  | — |  |  | — |  | — |  |  |  |  |
Expired | — |  | — |  |  | — |  | — |  |  |  |  |
Forfeited | — |  | — |  |  | — |  | — |  |  |  |  |
Ending balance | 73,440 |  | $ | 16.32 |  |  | 73,440 |  | $ | 16.32 |  |  |  |  |
As of March 31, 2024, all stock appreciation rights were exercisable and had a weighted average remaining term of 5.1 years. There was no unrecognized compensation cost for stock appreciation rights as of March 31, 2024. As of March 31, 2024 and December 31, 2023, the liability recorded for outstanding stock appreciation rights was $0.4 million and $0.6 million, respectively. The Company uses an option pricing model to value the stock appreciation rights, using the assumptions in the following table. Expected volatility is derived from the historical volatility of the Company’s stock price and a selected peer group of industry-related companies.
| March 31, 2024 |  | December 31, 2023
Risk-free interest rate | 4.21 | % |  | 3.85 | %
Expected volatility | 37.35 | % |  | 37.37 | %
Expected life (in years) | 5.4 |  | 5.7
Expected dividend yield | 3.99 | % |  | 3.22 | %
As of December 31, 2023, the liability recorded for previously exercised stock appreciation rights was $0.2 million which was paid in 2024.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration